Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 948 for “"combination therapy"”.

  1. Combination therapy in ischaemic stroke

    … ischaemia, remains the only clinically approved therapy. However, the 4.5 h “door-to-needle” time window observed with ischaemic stroke in addition to rt-PA’s potential haemorrhage risk, results in only 2 – 5 % of all stroke patients receiving this therapy. Stroke is therefore a disease with …

    glasgow Repository record for Combination therapy in ischaemic stroke (opens in a new tab) Download PDF for Combination therapy in ischaemic stroke (opens in a new tab)

  2. Medication Adherence to Antihypertensive Combination Therapy

    … are attributable to hypertension annually. Combination therapy in the treatment of hypertension has been shown to improve both blood pressure control and tolerability. Currently, only three single pill triple-combination therapies are available in the market for the treatment of …

    houston Repository record for Medication Adherence to Antihypertensive Combination Therapy (opens in a new tab)

  3. Targeted Molecular Imaging: A Guide to Combination Therapy

    … is widely used to deliver genes for cancer gene therapy. Coxsackie and Adenovirus' Receptor (CAR) is the primary receptor for recombinant adenovirus. Little attention has been paid to determine CAR protein expression and promoter activity in vivo. This study tested the hypothesis that targeted …

    utswmed Repository record for Targeted Molecular Imaging: A Guide to Combination Therapy (opens in a new tab)

  4. Targeted Combination Therapy Of Triple-Negative Breast Cancer

    TARGETED COMBINATION THERAPY OF TRIPLE-NEGATIVE BREAST CANCERby KETKI BHISE May 2021 Advisor: Dr. Arun Iyer Major: Pharmaceutical Sciences Degree: Doctor of Philosophy Triple Negative Breast Cancer (TNBC) accounts for 10-20% of the total breast carcinoma cases. There is no FDA-approved targeted …

    wayne-thes Repository record for Targeted Combination Therapy Of Triple-Negative Breast Cancer (opens in a new tab)

  5. Aurka inhibition-based combination therapy approaches in glioblastoma.

    … specific Aurora Kinase A inhibitor alisertib in combination with DNA-damaging platinum agent carboplatin or brain-penetrating taxane TPI 287. We investigated the efficacy of these combinations in treating in vitro and in vivo tissue culture models of glioblastoma. We utilized a wide range of …

    louisville Repository record for Aurka inhibition-based combination therapy approaches in glioblastoma. (opens in a new tab)

  6. Novel Combination Therapy: Monensin Potentiates Erlotinib-Induced Cytotoxicity

    … agents. As a result, RTK inhibitors require a combination based therapeutic approach with other treatment modalities. To uncover such a combination of agents, we performed a high throughput Prestwick library screen that included 1200 compounds approved by the FDA on HNSCC cell lines and found …

    ottawa-retro Repository record for Novel Combination Therapy: Monensin Potentiates Erlotinib-Induced Cytotoxicity (opens in a new tab)

  7. Stimuli responsive smart-gel trapped particles for combination therapy

    … as a delivery platform for delivering a combination of hydrophilic and hydrophobic drugs in combination management therapy. The purpose of this is to serve as an alternative for treatment of chronic conditions such as type 2 diabetes, where dosage forms often fail to meet expectations. …

    strathclyde Repository record for Stimuli responsive smart-gel trapped particles for combination therapy (opens in a new tab)

  8. Combination Therapy For the Treatment of Human Malignant Neuroblastoma

    … therapeutic approaches including chemotherapy, radiation therapy, immunotherapy, and neurosurgery, the survival rate of children affected with advanced stage neuroblastoma remains significantly low. Therefore, there is an urgent need to develop innovative therapeutic approaches to …

    south-carolina Repository record for Combination Therapy For the Treatment of Human Malignant Neuroblastoma (opens in a new tab)

  9. COMBINATION THERAPY FOR CANCER TREATMENT USING MULTICOMPONENT DRUG AMPHIPHILE SYSTEMS

    … (RCP-5) were used to develop four different combination systems aiming to release therapeutics in controlled and unique ways.By mixing the TT-6 and RCP-5 at a monomeric level, filaments equally comprising both monomers were formed. During release studies, it was found that this system …

    jhu Repository record for COMBINATION THERAPY FOR CANCER TREATMENT USING MULTICOMPONENT DRUG AMPHIPHILE SYSTEMS (opens in a new tab)

  10. Developing combination therapy to improve viral vector cancer vaccine efficacy

    … Undeniably, it is necessary to develop treatment combination strategies to overcome the multitude of mechanisms that cancer cells use to escape the immune system. However, to successfully combine therapies and generate synergy, research is needed to comprehend their respective therapeutic …

    oxford Repository record for Developing combination therapy to improve viral vector cancer vaccine efficacy (opens in a new tab)

  11. Investigation on nanoparticle based combination therapy for targeted cancer treatment

    “The current treatment methods in cancer are associated with toxicity in healthy tissues, partial therapeutic response, drug resistance and finally recurrence of the disease. The cancer drugs are challenged by non-specific binding, undesired toxicity in healthy cells, low therapeutic index and …

    must-thes Repository record for Investigation on nanoparticle based combination therapy for targeted cancer treatment (opens in a new tab)

  12. COMBINATION THERAPY THROUGH PLATINUM (IV) PRODRUG COMPLEXES INCORPORATING SELF-IMMOLATING LINKERS

    … by low selectivity and severe side effects. In combination chemotherapy, drugs with different physical properties may also not be delivered synchronously. We investigated the conjugation of cisplatin to a synergistic drug using a self-immolating linker, aiming to create a Pt(IV) complex which …

    nus Repository record for COMBINATION THERAPY THROUGH PLATINUM (IV) PRODRUG COMPLEXES INCORPORATING SELF-IMMOLATING LINKERS (opens in a new tab) Download file for COMBINATION THERAPY THROUGH PLATINUM (IV) PRODRUG COMPLEXES INCORPORATING SELF-IMMOLATING LINKERS (opens in a new tab)

  13. Actinomycin D and Telmisartan Combination Therapy Targets Lung Cancer Stem Cells

    … these drawbacks, we tested AD treatment in combination with the angiotensin receptor antagonist, Telmisartan (TS) because it has been reported to reduce fibrosis in tumors allowing them to be more permeable to drugs. We have found that this novel combination treatment is effective in …

    usf Repository record for Actinomycin D and Telmisartan Combination Therapy Targets Lung Cancer Stem Cells (opens in a new tab)

  14. Survivin: Regulation by YY1 and Role in Pancreatic Cancer Combination Therapy

    … importance to improving cancer management and therapy. Our work has identified a novel transcriptional regulator of survivin called Yin Yang 1 (YY1). YY1 is a transcription factor that has been observed to activate some gene promoters and repress others, and it is gaining increasing interest as …

    loma-linda Repository record for Survivin: Regulation by YY1 and Role in Pancreatic Cancer Combination Therapy (opens in a new tab)

  15. Oncolytic Vesicular Stomatitis Virus and Sunitinib Combination Therapy for Treating Neuroblastoma

    … (neuro-2a), we found that VSVΔM51/sunitinib combination therapy elicited superior tumour regression and durable cure rates compared to either agent alone. We tested sunitinib’s ability to enhance infection in neuro-2a tumours, however, we found that infection with or without sunitinib was …

    calgary Repository record for Oncolytic Vesicular Stomatitis Virus and Sunitinib Combination Therapy for Treating Neuroblastoma (opens in a new tab)

  16. Towards malaria combination therapy: Characterization of hybrid molecules for HIV/malaria combination therapy and of thiostrepton as a proteasome-targeting antibiotic with a dual mode of action

    … HIV simultaneously for a potential HIV/malaria combination therapy. Hybrid molecules were synthesized by covalent fusion between azidothymidine (AZT) and dihydroartemisinin (DHA), tetraoxane or chloroquine (CQ); and a small library was generated and tested for antiviral and antimalarial …

    wurz-thes Repository record for Towards malaria combination therapy: Characterization of hybrid molecules for HIV/malaria combination therapy and of thiostrepton as a proteasome-targeting antibiotic with a dual mode of action (opens in a new tab)

  17. DEVELOPING STIMULI RESPONSIVE DEVICES FOR COMBINATION THERAPY TRIGGERED ADAPTIVE IMMUNITY AGAINST GLIOBLASTOMA

    … involves maximal safe resection followed by radiotherapy in combination with chemotherapy (temozolomide). However, due to the difficulty in clearing microscopic residual disease at the margins of resection due to their proximity to the eloquent cortex, complete tumor excision remains an enormous …

    nus Repository record for DEVELOPING STIMULI RESPONSIVE DEVICES FOR COMBINATION THERAPY TRIGGERED ADAPTIVE IMMUNITY AGAINST GLIOBLASTOMA (opens in a new tab) Download file for DEVELOPING STIMULI RESPONSIVE DEVICES FOR COMBINATION THERAPY TRIGGERED ADAPTIVE IMMUNITY AGAINST GLIOBLASTOMA (opens in a new tab)

Page 1 of 48